EATON VANCE MANAGEMENT - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$384,000
+13.3%
23,0620.0%0.00%
Q2 2022$339,000
-40.7%
23,0620.0%0.00%
-100.0%
Q1 2022$572,000
-22.7%
23,0620.0%0.00%0.0%
Q4 2021$740,000
-90.2%
23,062
-89.0%
0.00%
-90.0%
Q3 2021$7,529,000
+44.5%
209,251
+77.1%
0.01%
+42.9%
Q2 2021$5,212,000
+67.2%
118,124
+73.4%
0.01%
+40.0%
Q1 2021$3,117,000
-77.4%
68,141
-65.9%
0.01%
-54.5%
Q4 2020$13,804,000200,0000.01%
Other shareholders
PULMONX CORP shareholders Q2 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders